Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Exp Hematol. 2011 Oct 20;40(1):84–91. doi: 10.1016/j.exphem.2011.10.001

Figure 2. Transient silencing of PTEN increases entry of human CD34+ cells into cell cycle.

Figure 2

(A) Representative cell cycle analysis comparing G0, G1, and S/G2-M phases between PTEN1, PTEN2, and control siRNA treated CD34+ cells 3 days after transfection. (B) Mean percentages (± SD, n=3, t-test) of control or PTEN siRNA-treated CD34+ cells in G0 and S/G2+M phases of the cell cycles 3 days after transfection. *p<0.05; **p<0.01